Clinical Trials Browser

Withdrawn × OTHER × orteronel × Clear all

NCT02053311 2018-07-30

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Phase 3 Withdrawn

Prostatic Neoplasms

NCT02054793 2014-07-23

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms